This clinical trial aims to test new treatments for a type of liver cancer called **intrahepatic cholangiocarcinoma**, which often comes back after surgery. The study combines several advanced treatments: **HAIC** (Hepatic Arterial Infusion Chemotherapy), **GEMOX** (a combination of drugs gemcitabine and oxaliplatin), **Adebrelimab** (a type of medicine that helps the immune system fight cancer), and **Lenvatinib** (a medicine that stops cancer growth). These are used before surgery to see if they can reduce the cancer, making it easier to remove.

• The study involves 2-4 cycles of treatment before surgery.
• Participants must be aged between 18-75 and meet certain health criteria.
• Participants should expect to follow specific guidelines regarding contraception during the study.

Doctors will measure how well the cancer shrinks with these treatments, and whether the combination is safe for patients. If you're considering joining this study, it's important to discuss any concerns with your doctor, especially regarding the required treatment cycles and potential side effects. 🏥💉